SureTrader
Home > Boards > US OTC > Medical - Drugs >

Bioelectronics Corp. (BIEL)

BIEL RSS Feed
Add BIEL Price Alert      Hide Sticky   Hide Intro
Moderator: yankee55, stockdarockk, REDZONE, Det_Robert_Thorne, dcsteve, seven-up
Search This Board:
Last Post: 8/25/2016 8:35:28 PM - Followers: 563 - Board type: Free - Posts Today: 92















http://finance.yahoo.com/news/bioelectronics-applauds-fdas-reclassification-nonthermal-123000975.html





Based on the comments from the 2013 Panel meeting, the comments received in response to FDA's prior proposed rule (77 FR 39953, July 6, 2012), and FDA's assessment of new, valid scientific data related to the health benefits and risks associated with nonthermal SWT, FDA is proposing that these devices should be reclassified from class III to class II 
http://www.ofr.gov/(S(rsqvwlmlrgnufyk2vypn53y2))/OFRUpload/OFRData/2014-03594_PI.pdf


Its Important to understand 

FDA pretty much changed the guidelines based on the clinical data and CEO Presentation, which in return confirms the products... 

In other words its compared to a (drug approval) that takes years of research and clinical data to get to this point... 

This move by the FDA awakens the Pharmaceutical companies and investment firms .... guys over the next 2weeks the word will get out and since BIEL already has products and patents which was granted in April 2013,... I'm thinking by December this baby could be high .20-30 


- They already have Boots in UK which is part of Walgreen so expand into Walgreen, followed by many other sources...
 

 

MUST SEE  http://www.bielcorp.com/biel/wp-content/uploads/2014/01/Bioelectroceuticals-Mechanism-of-Action-Clinical-Evidence-Version-16.pdf


The Company

http://www.sec.gov/Archives/edgar/data/1320869/000120445906000825/exh1014.htm
 

We are the makers of ActiPatch Therapy, RecoveryRx Devices, HealFast Therapy and the Allay family of inexpensive, disposable drug-free anti-inflammatory devices.

Our revolutionary line of pain treatment products are sold in more than 35 countries, with the simple goal of changing the way people heal.

Patents::::   
https://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Bioelectronics+Corp.%22
 

Electromagnetic therapy device and methods

www.google.com/patents/US8412328
Grant - ‎Filed May 21, 2003 -Issued Apr 2, 2013 - ‎Andrew J. Whelan - ‎Bioelectronics Corp.
Systems and techniques for applying an electromagnetic field to bodily tissue include a self-contained and portable electromagnetic field ...
Overview - ‎Related - ‎Discuss
 

Electromagnetic therapy device

www.google.com/patents/EP1606010B1?cl=en
Grant - ‎Filed Mar 3, 2004 - ‎Issued Feb 22, 2012 - ‎Andrew J. Whelan - ‎Bioelectronics Corp.
Systems and techniques for applying an electromagnetic field to bodily tissue include a self-contained and portable electromagnetic field ...
Overview - ‎Related - ‎Discuss
 

Back pain belt

 

www.google.com/patents/USD638949
Grant - ‎Filed May 11, 2010 - ‎Issued May 31, 2011 - ‎John R. Martinez - ‎BioElectronics Corp.
FIGS. 1-7 are views of a back pain belt with an electromagnetic pulse delivery device inside the a mesh pocket on the belt. FIG. 1 is a front ...
Overview - ‎Related - ‎Discuss
 

Product package

BioElectronics is changing the way people heal around the world.  Our vision is to provide our highly effective and safe technological solution so people can live their lives pain-free. We recently received the "2009 Wall Street Journal Technology Innovation Awards" with our unique anti-inflammatory technology that reduces pain and edema. This technology is the platform for everything that we do. Our current strategic vision is to develop a number of strong brands that build upon our technological platform. Currently, the main applications are aimed at the OTC markets for back pain, knee pain and menstrual pain. We hope to introduce our technology to new markets and additional countries in the near future.  We look forward to serving you!

Retail Products 

What is ActiPatch®?
Recognized by the Wall Street Journal as one of the top medical innovations of 2009, ActiPatch® delivers its patented BioDynamic Therapy to not only relieve your pain, but to HEAL it so it doesn't come back.  Drugs and heat patches don't work to cure your pain - they simply mask it.  It always comes back.  Introducing a breakthrough in pain relief!


How does ActiPatch® work?

When cells are damaged, inflammation sets in resulting in pain, swelling, and reduced cellular energy.  ActiPatch® calms the inflammation and restores cells to their normal energy levels.  The result:  your pain and swelling diminish and your damaged cells actually begin to heal for sustained relief.  For more information visit the Technology section of our web site.

Is ActiPatch® Safe?

ActiPatch® is extremely safe and comfortable to wear. The low level current that is gently pulsed into damaged tissue is undetectable, even though the device is continuously working to help you heal. 



 


 

  http://www.allaystore.com

 

 

 

What is Allay? 

Allay is a safe, drug-free solution to pain and discomfort associated with menstruation. Recognized by the Wall Street Journal as one of the top medical innovations of 2009, Allay draws on an innovative delivery system which emits low-level energy pulses which quickly relieve edema, inflammation, and pain, providing patient comfort and speeding up the onset of natural healing. Allay is recommended by physicians as a safe and effective treatment. In fact, clinical study results show that 77.1% of women using Allay reported complete elimination or significant reduction in their typical menstrual symptoms.

What's Inside?

Allay is a miniaturized medical device which delivers low-level energy pulses into your abdominal region to lessen contractions and alleviate the pain and discomfort resulting from menstruation. The unit consists of a control module containing the wafer-thin microchip and battery, which is connected to a flexible loop that bends to meet the contours of a woman's body. The control unit and loop are contained within a soft, hypoallergenic biodegradable sleeve ("Wrap") that is comfortably worn against the skin at the site of menstrual pain, cramping, and discomfort.

Inside the box, you will find:

  • 1 12cm Allay Loop Device Inside a Cloth Wrap
    1 Pouch (Allay device inside)
    9 Additional Cloth Wraps!
Allay is currently being sold in over 40 countries worldwide.

 
HealFast®  Therapy is a drug-free therapy for horses, cats and dogs that reduces swelling and pain while it speeds healing of muscle and tendon injuries, sores and incisions.   Animal muscle and skin tissues are composed of cell networks in which cell-cell communication relies extensively on cell-cell contact.   When there is an injury in soft tissue from whatever source - cut, sprain, arthritis - the swelling tissues disrupt cell-cell communication and delay healing.   HealFast therapy acts on the cells within a tissue boosting the energy in the cell membrane returning tissues to healthy function faster.
 

To receive investor updates via e-mail, please contact us at IR@bielcorp.com with your name and e-mail address. Updates are posted every other Thursday. Thank you for your support!

Market Clearances

BioElectronics Corporation Worldwide Class IIa OTC Market Clearances

Country

Menstrual Pain

Musculoskeletal Pain

Postoperative Recovery/Chronic Wounds

All European Union Countries

x

x

x

Australia

x

x

x

Canada

x

x

x

China

   

Working on Clearance

Colombia

x

x

x

Croatia

x

x

x

India

 

Working on Clearance

 

Iran

x

x

x

Israel

x

x

x

Italy

x

x

x

Jordan

x

x

x

Korea

 

x

 

Kuwait

x

x

x

Mexico

Working on Clearance

Working on Clearance

Working on Clearance

Morocco

x

x

 

New Zealand

x

x

x

Nigeria

x

x

x

Peru

x

x

x

Spain

x

x

x

United States

Working on Clearance

Working on Clearance

Class III

Taiwan

Working on Clearance

Working on Clearance

Working on Clearance

Venezuela

Working on Clearance

Working on Clearance

Working on Clearance


                                                                                                                                                                                                        
Distributors

To order ActiPatch® online from Canada, please visit www.actipatch.ca

To order ActiPatch® online from Europe, please visit www.actipatchrelief.co.uk

 

Territory

Distributor

Products Distributed

Website

Albania Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Andorra Palex Medical SA ActiPatch, Allay & RecoveryRx www.palexmedical.com/en/
Australia Emergy Products ActiPatch, Allay & RecoveryRx www.emergyproducts.gr
Bosnia & Herzegovina Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Bulgaria Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Canada (ActiPatch online) BioElectronics Corporation ActiPatch www.actipatch.ca
Canada (ActiPatch online) Clearpoint Direct ActiPatch www.clearpointdirect.com
Canada (Allay online) BioElectronics Corporation Allay www.allaystore.com
China Shanghai Lixiu Medical Devices Co. RecoveryRx www.surgithes.com
Costa Rica Alfa Medica S.A. ActiPatch & Allay www.alfamedicacr.com
Croatia Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Cyprus Emergy Products ActiPatch, Allay & RecoveryRx www.myactipatch.gr, www.myallay.gr
Czech Republic easyMed s.r.o. ActiPatch & RecoveryRx www.easy-med.us
Denmark Maersk - Anderson ActiPatch & Allay www.c-m-a.dk
Ecuador Alboquin S.A. RecoveryRx & Allay www.maxbetsa.com
El Salvador Red-Medyci, S.A de C.V. ActiPatch, Allay & RecoveryRx www.redmedyci.com
Europe (online) Amazon UK ActiPatch & Allay www.actipatchrelief.co.uk
Greece Emergy Products ActiPatch, Allay & RecoveryRx www.myactipatch.gr, www.myallay.gr
Guatemala Red-Medyci, S.A de C.V. ActiPatch, Allay & RecoveryRx www.redmedyci.com
India Juno Pharmaceuticals ActiPatch www.actipatch.in
Iran Nik Day Arya Co., Ltd ActiPatch, Allay & RecoveryRx

-

Ireland O'neill healthcare RecoveryRx

-

Israel International Medical Trade & Consultants ActiPatch, Allay & RecoveryRx www.imtc.co.il
Jordan Achilles Medical ActiPatch www.achilles.com
Kosovo Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Macedonia Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Malaysia Qianjing Malaysia ActiPatch & Allay www.qjmedic.com
Malta Sidroc ActiPatch www.sidroc.com
Montenegro Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Morocco Noveq LLC. ActiPatch & Allay www.noveq.com
New Zealand Emergy Products ActiPatch, Allay & RecoveryRx www.emergyproducts.gr
Nigeria Alpha Pharmacy and Stores Ltd. ActiPatch & Allay www.alphapharmacyltd.com
Portugal Palex Medical SA ActiPatch, Allay & RecoveryRx www.palexmedical.com/en/
Saudi Arabia Sultanah Holding Group ActiPatch, Allay & RecoveryRx www.sultanahholding.com
Serbia Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Singapore Astonix ActiPatch, Allay & RecoveryRx www.astonixlife.com
Slovenia Zephyrus d.o.o. ActiPatch, Allay & RecoveryRx www.akomed.com
Spain Palex Medical SA ActiPatch, Allay & RecoveryRx www.palexmedical.com/en/
Venezuela Comercializadora Almed ActiPatch & RecoveryRx

-



~BioElectronics Corporation Website~
http://bielcorp.com/

State of Incorporation: MD
Year of Incorporation 2000

~BioElectronics Corporate Headquarters~
4539 Metropolitan Ct.
Frederick, MD 21704
Toll Free: 866-757-2284
Phone: 301-874-4890
Fax: 301-644-3937

Office Hours:
9 A.M. - 5 P.M. EST

E- mail:info@actipatch.net


$$$$$==Updates for 2014 / Products / FDA ==$$$$$ 


2014 Oxford Pharmascience Group (OXP) is sponsoring BIELhttp://www.oxfordpharmascience.com/content/investors/share_price.asp 

Park Lane Hotel, Piccadilly, London 
Thursday, 6th March 2014
 

http://www.otc-bulletin.com/awards/pdfs/Nominations-Supplement-2014.pdf 
 


Additional Products Improvements 2014 http://chiropractorofthefuture.com/ 
 
 

$$$$$==BIEL DD POSTED 02/13/14==$$$$$ 

 From Oct 2013 ::: The innovation award we won from OTC Bulletin in March has yielded more than a good-looking plaque. Our products caught the attention of several interested parties including three of Europe’s largest pharmaceutical companies. We are actively exploring distribution and co-branding licensing proposals with all three. In each case these proposals offer significant potential advantages to the company. The most immediate would be product sales to companies with well-established, funded marketing and sales channels, and licensing agreements with royalty income. This strategy maintains our first-to-market advantage while giving us access to a good income stream and marketing power and access to capital (without further dilution). Another advantage would be the spill-over affect associated with this co-branding alliance on our other brands and obtaining additional distribution in other regions. http://www.bielcorp.com/investors/letter-from-the-president/ 

 
2014 Oxford Pharmascience Group (OXP) is sponsoring BIELhttp://www.oxfordpharmascience.com/content/investors/share_price.asp 

Park Lane Hotel, Piccadilly, London 
Thursday, 6th March 2014 

http://www.otc-bulletin.com/awards/pdfs/Nominations-Supplement-2014.pdf 

 

 

Now in over 20 US Location for sale Additional Products Improvements 2014http://chiropractorofthefuture.com/ 
 

 

LOOKS LIKE AN UPDATE ON 2014 FDA 

Updated by FDA :::: 
2014 


http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?start_search=1&OwnerOperatorNumber=10028114

Now listed as Active 
http://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfRL/rl.cfm?rid=98022 

 
Patents:::: https://www.google.com/search?tbo=p&tbm=pts&hl=en&q=inassignee:%22Bioelectronics+Corp.%22

 

 
 

 



Approved for Olympics:                                                                                LOOK AT DR Oz
 

 didn't notice that the FDA had uploaded additional info from the meeting, including a summary. IMO, things are pointing towards Class II w/ a lot of special controls. Probably looking at months away from a final order (see page 20 of Reclassification Process). 


FDA Presentation 
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/OrthopaedicandRehabilitationDevicesPanel/UCM354307.pdf 

Brief Summary of the Meeting 
Note: Debate over potential unreasonable risk of injury or illness which is key to Class II or III designation 
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/OrthopaedicandRehabilitationDevicesPanel/UCM354284.pdf 

Reclassification Process Flow Chart 
Note: Page 18 w/ respect to panel & FDA stating there is sufficient data to establish special controls. 
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/OrthopaedicandRehabilitationDevicesPanel/UCM354300.pdf 

Nonthermal SWD Regulatory Background 
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/OrthopaedicandRehabilitationDevicesPanel/UCM354304.pdf 

Intro & Reg Reference Sheet 
http://www.fda.gov/downloads/AdvisoryCommittees/CommitteesMeetingMaterials/MedicalDevices/MedicalDevicesAdvisoryCommittee/OrthopaedicandRehabilitationDevicesPanel/UCM352572.pdf 



 

Welcome to Boots

The UK's leading pharmacy-led health and beauty retailer

Boots UK is a member of Alliance Boots, an international pharmacy-led health and beauty group.

Our purpose is to help our customers look and feel better than they ever thought possible.  We have close to 2,500 stores from local community pharmacies to large destination health and beauty stores.  We offer fantastic products and services and you'll be cared for by expert, friendly people.   http://www.boots-uk.com/   
 

Walgreen to Spend $6.7 Billion on Alliance Boots Stake - WSJ.com  

 

 
 
 

BioElectronics Investor Updates

 

Tuesday, February 11, 2014

ActiPatch® and Smart Insole™ Pain Relief Products Nominated for Marketing Awards by the OTC Bulletin
ActiPatch® and Smart Insole™ Pain Relief Products Nominated for Marketing Awards by the OTC Bulletin

 

Recent Updates


GlaxoSmithKline wires up $50M VC fund for bioelectronic treatment effort

Read more: 
GlaxoSmithKline wires up $50M VC fund for bioelectronic treatment effort - FierceBiotech http://www.fiercebiotech.com/story/glaxosmithkline-wires-50m-vc-fund-bioelectronic-treatment-effort/2013-08-08#ixzz2tN79rRsT 
Subscribe at FierceBiotech


01/31/2014 ---  http://www.cricketworld.com/win-actipatch-for-pain-free-living/36496.htm

 

ActiPatch, a musculoskeletal pain reliever

December 12, 2013 @ 10:14 am · Filed under Pain Management

Dr. Christine Dumas, public affairs spokesperson and patient advocate for BioElectronics Corporation, the maker of ActiPatch, which reduces musculoskeletal pain in different areas of the body joins eHealth Radio and the Pain Management Channel.    http://ehealthradio.podbean.com/?s=dumas 

 






Disclaimer:

This Un-Official BIEL Message Board was created by shareholders of BIEL for Shareholders of BIEL. The intent of this board is to help shareholders and also bring discussions about BIEL to a central place.
Information above is gathered from either the internet or from other sources that could prove to be unreliable. Please do your own Due Diligence as some information may be out of date. IHub and the Moderators of this board (BIEL) will not claim nor hold any responsibility for a person(s) financial decisions. If any in-valid information is located on the BIEL board, please notify one of the moderators immediately so corrections can be made.
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
BIEL
Current Price
Volume:
Bid Ask Day's Range
SureTrader
PostSubject
#82157  Sticky Note BioElectronics Company Updates seven-up 08/22/16 09:08:43 AM
#82086  Sticky Note Hahahahah Can't resist the nonsensical content of Simpsonly 08/20/16 11:02:17 PM
#82010  Sticky Note Folks, the topic for discussion here is BIEL. IH Admin [Edward] 08/19/16 07:37:40 PM
#80948  Sticky Note FDA updated ACTIPATCH today 08/02/16-to=Device-class II OTC REDZONE 08/02/16 12:00:23 PM
#77668  Sticky Note Revenue: $528K, Net Loss: $457K, OS: 11.1B Det_Robert_Thorne 05/13/16 02:59:19 PM
#71363  Sticky Note ****SEC litigation against BIEL - Link***** MUST_ SEE_BEFORE_BUYING_SCAM!!!! stockdarockk 02/07/16 10:37:09 PM
#65459  Sticky Note Approval on the way- what changed since 2010 denial- dcsteve 12/06/15 08:12:58 PM
#82482   Wow, it will be the most significant perfect DewmBoom 08/25/16 08:35:27 PM
#82481   FDA green light for Actipatch will follow soon! yankee55 08/25/16 08:01:10 PM
#82480   Thanks PM, We are so involved in the srinsocal 08/25/16 07:55:48 PM
#82479  Restored A stay in the proceedings means they have NoPinkScams 08/25/16 07:24:11 PM
#82477   Great post PitchMan. You're exactly right. toohot 08/25/16 07:04:49 PM
#82476   All of D.C. getting in on the act: PitchMan 08/25/16 06:56:24 PM
#82475   But who cares, whatever the SEC is doing DewmBoom 08/25/16 05:22:45 PM
#82474   Just so you know, charges would be "dismissed", Simpsonly 08/25/16 05:01:35 PM
#82473   So in your opinion is it good or Steve43 08/25/16 03:28:39 PM
#82472   So what are you telling me, that a Steve43 08/25/16 03:24:28 PM
#82471   uhhhhh, there may just be another, more fair Simpsonly 08/25/16 03:20:14 PM
#82470   "Stayed.... based upon their agreement in principle to GetSeriousOK 08/25/16 03:11:02 PM
#82469   There is no proof of any of the seven-up 08/25/16 03:08:33 PM
#82468   Hey toohot, good post - I think honest, Simpsonly 08/25/16 03:07:46 PM
#82464   And that was just Kelly and just two stockdarockk 08/25/16 02:35:44 PM
#82463   I think U are missing the point here DewmBoom 08/25/16 02:16:19 PM
#82462   Yes, you are invested shado, and wise too. Simpsonly 08/25/16 02:15:42 PM
#82461   As a long since 2009 I have the shadolane 08/25/16 02:06:18 PM
#82460   You're still missing it . . . . Simpsonly 08/25/16 02:03:38 PM
#82459   I hear the rumbling, the Big Bang is DewmBoom 08/25/16 02:03:34 PM
#82458   Can't believe you are jumping to conclusions without Simpsonly 08/25/16 01:52:11 PM
#82457   All I will say is that you don't fuente 08/25/16 01:51:15 PM
#82456   All I will say is that you don't Simpsonly 08/25/16 01:43:14 PM
#82455   So, for me, and me alone, the issue fuente 08/25/16 01:21:13 PM
#82454   That is the question and I'm not sure Simpsonly 08/25/16 01:17:31 PM
#82453   The content of that post is totally false fuente 08/25/16 01:12:02 PM
#82452   It's a statement of fact actually. Confirmed NoPinkScams 08/25/16 01:07:48 PM
#82451   Thank U SEC for investigating Biel for our DewmBoom 08/25/16 01:06:14 PM
#82449   Exactly. Perhaps Bedwell gave them the keys fuente 08/25/16 01:00:07 PM
#82448   Was the finance model illegal per SEC regulations? fuente 08/25/16 12:58:34 PM
#82447   There was tons of secret personal financial gain. NoPinkScams 08/25/16 12:56:47 PM
#82446   Did you even read it? It has NoPinkScams 08/25/16 12:54:12 PM
#82445   Good post - shows wisdom - The questions Simpsonly 08/25/16 12:52:53 PM
#82444   Slapp it !!!!!! Moke31 08/25/16 12:27:34 PM
#82443   I thought the charge was "stayed" but even Steve43 08/25/16 12:26:10 PM
#82442   Or... This is the first step in rolling out fuente 08/25/16 12:25:33 PM
#82441   If they found nothing then the charges would NoPinkScams 08/25/16 12:17:31 PM
#82440   Actipatch will soon be in the spotlights with yankee55 08/25/16 12:10:22 PM
#82439   Maybe they found nothing? Maybe the case is Steve43 08/25/16 12:05:54 PM
#82438   You are so correct Simpsonly, the FDA made yankee55 08/25/16 12:03:59 PM
#82437   I see your statement that reads "I want Steve43 08/25/16 12:02:46 PM
#82436   Looks like from the admin proceedings, Bedwell has fuente 08/25/16 11:56:47 AM
#82434   Yes you finally get some of what advertising Steve43 08/25/16 11:54:06 AM
#82433   my take on that is in fact it uksausage 08/25/16 11:43:33 AM
#82431   For the six months ended June 30, 2016, seven-up 08/25/16 11:12:03 AM
#82430   And FDA has now completed their due diligence rodman 08/25/16 11:10:41 AM
#82429   It's the same old story (see below) with Simpsonly 08/25/16 10:57:34 AM
#82426   The SEC can deny BIEL the right to GetSeriousOK 08/25/16 10:19:51 AM
#82425   It is simple. They don't want to, and GetSeriousOK 08/25/16 10:11:45 AM
#82422   It is simple. They don't want to, and DewmBoom 08/25/16 09:52:25 AM
PostSubject